- Home
- KALA vs TOMZ Comparison
KALA vs TOMZ Comparison
Compare KALA & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- TOMZ
- Stock Information
- Founded
- KALA 2009
- TOMZ 1979
- Country
- KALA United States
- TOMZ United States
- Employees
- KALA N/A
- TOMZ N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- TOMZ Diversified Commercial Services
- Sector
- KALA Health Care
- TOMZ Finance
- Exchange
- KALA Nasdaq
- TOMZ Nasdaq
- Market Cap
- KALA 26.2M
- TOMZ 22.6M
- IPO Year
- KALA 2017
- TOMZ N/A
- Fundamental
- Price
- KALA $4.03
- TOMZ $1.03
- Analyst Decision
- KALA Strong Buy
- TOMZ Strong Buy
- Analyst Count
- KALA 3
- TOMZ 1
- Target Price
- KALA $14.00
- TOMZ $3.50
- AVG Volume (30 Days)
- KALA 38.5K
- TOMZ 34.7K
- Earning Date
- KALA 08-05-2025
- TOMZ 07-31-2025
- Dividend Yield
- KALA N/A
- TOMZ N/A
- EPS Growth
- KALA N/A
- TOMZ N/A
- EPS
- KALA N/A
- TOMZ N/A
- Revenue
- KALA N/A
- TOMZ $8,201,313.00
- Revenue This Year
- KALA N/A
- TOMZ $3.66
- Revenue Next Year
- KALA N/A
- TOMZ $139.63
- P/E Ratio
- KALA N/A
- TOMZ N/A
- Revenue Growth
- KALA N/A
- TOMZ 19.09
- 52 Week Low
- KALA $2.92
- TOMZ $0.60
- 52 Week High
- KALA $11.20
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- KALA 53.41
- TOMZ 54.29
- Support Level
- KALA $4.10
- TOMZ $1.09
- Resistance Level
- KALA $4.41
- TOMZ $1.14
- Average True Range (ATR)
- KALA 0.39
- TOMZ 0.08
- MACD
- KALA 0.01
- TOMZ -0.01
- Stochastic Oscillator
- KALA 52.39
- TOMZ 50.00
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.